1.
A preliminary report on the use of Midodrine in treating refractory gastroesophageal disease: Randomized Double-Blind Controlled Trial: Midodrine and refractory gastroesophageal disease. Acta Biomed [Internet]. 2020 Mar. 19 [cited 2024 Jun. 12];91(1):70-8. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/8486